Showing results (11-20 of 535) with videos related to
Sort By:
Pageof 54
Nature Reviews. Neurology|February 15, 2012
Chronic migraine--classification, characteristics and treatmentHans-Christoph Diener, David W Dodick, Peter J Goadsby, et al.Cephalalgia : an International Journal of Headache|May 22, 2019
Early onset of effect of onabotulinumtoxinA for chronic migraine treatment: Analysis of PREEMPT dataDavid W Dodick, Stephen D Silberstein, Richard B Lipton, et al.Headache|April 8, 2017
Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: Guidance on Achieving Optimal OutcomesAndrew M Blumenfeld, Stephen D Silberstein, David W Dodick, et al.Pain and Therapy|October 7, 2020
Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT AnalysisHans-Christoph Diener, David W Dodick, Richard B Lipton, et al.Pain and Therapy|October 7, 2020
The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic MigraineStephen D Silberstein, Hans-Christoph Diener, David W Dodick, et al.Headache|May 11, 2019
Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter TrialDavid Yarnitsky, David W Dodick, Brian M Grosberg, et al.Neurology|September 11, 2020
Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized studyPeter J Goadsby, Stephen D Silberstein, Paul P Yeung, et al.Headache|April 5, 2011
MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraineSheena K Aurora, Stephen D Silberstein, Shashidhar H Kori, et al.Medicine|July 27, 2023
Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impactCatherine C Turkel, Sheena Aurora, Hans-Christoph Diener, et al.Journal of Neurology, Neurosurgery, and Psychiatry|December 16, 2014
Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPTStephen D Silberstein, David W Dodick, Sheena K Aurora, et al.Pageof 54